Now wouldnt it be great if the company quickly followed up
Now wouldnt it be great if the company quickly followed up with similar for GenSure! and GenChoice!?
GenSure is not sold in the U.S. because there is no base of meters to sell at in the U.S. GenSure may be Hurricane Willy's sole focus and the current object of his hate, but it makes no sense to spend money on commercial advertising on a product that has no U.S. market. As for GenChoice, it is not FDA cleared yet, so it is unlawful to advertise a product that is not pre-market cleared.
But I would be surprised if commercials were not ready to go to sell GenSure in Mexico and India, and GenChoice when it is cleared. KB, no matter what the geniuses on iHub say, has about 40 years of experience marketing these products.
I remember a time when KB worked for BMD (a favorite company of weaver) where he brought into the U.S. a multi-phasic chemistry analyzer called the Hitachi 747 for sale to hospitals. To launch the product he brought in 5 of the analyzers which were 4' X 6' and built BMD's trade show booth into the body of a Boeing 747 that he rented from Flying Tigers.Thousands of medical technologists and clinical chemists were paraded through the 747. In 8 days that 747 visited 23 major cities in the U.S. and Canada and was covered by the (then) 3 major networks and dozens of local media.
I am wondering if the CEO to be, Hurricane Willy, would do something as creative.
2
Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Understanding Oscar Health's Recent Options Activity In the fast-paced world of trading, Oscar Health Inc’s (NYSE: OSCR) recent options activity has captured significant attention among savvy investors. Notably, there has been a notable bullish sentiment from wealthy investors towards this health insurance company. Tracking public options data reveals movements that...
Continue Reading
Better Choice Company Settles on Halo Asia Sale Better Choice Company, Inc. (BTTR), a leader in pet health and wellness, has recently reached a significant milestone by signing a definitive agreement to sell its Halo business in Asia. This sale is projected to generate total gross proceeds of $8.1 million, which encompasses $6.5 million in cash at the closing of the deal....
Continue Reading
Fastenal Prepares for Earnings Report Fastenal (NASDAQ: FAST) is gearing up to release its quarterly earnings report. Investors are keenly anticipating the upcoming announcement, as it offers a glimpse into the company's financial performance. This article provides essential insights and analysis for those eager to understand what to expect from Fastenal's announcement....
Continue Reading
Compass Therapeutics Advances Cancer Research BOSTON — Compass Therapeutics, Inc. (Nasdaq: CMPX), a promising player in the biotechnology sphere focused on developing innovative therapies for cancer, has made significant strides in its clinical research. The company has announced that the first patient has been dosed in a groundbreaking Investigator Sponsored Trial...
Continue Reading
Overview of the ECB Fine Imposed on LHV Group The European Central Bank (ECB) has recently informed AS LHV Group about a decision to levy an administrative fine amounting to EUR 405 thousand. This fine is linked to an error identified in the consolidated regulatory reporting for a specified timeframe. The issue arose from discrepancies in how the equity of LHV Bank...
Continue Reading